Life Sciences Insurance and Risk Management

Global expertise for clinical trial protection

The Gallagher Life Sciences insurance experts have developed risk management programs for every phase of the clinical trial process — from discovery to development to delivery; we have proven expertise in closing gaps to support you with comprehensive coverage. Our team has developed insurance and risk management programs for aspects of insuring human clinical trials in all 50 states and in over 50 countries.

Helping life science companies succeed

Our team consults about all matters relating to life sciences risk management for organizations ranging from drug manufacturers to contract manufacturing organization (CMO) to large publicly traded medical companies. Our experience and history in the business gives us actionable insight into the many layers and sectors of this dynamic field. We develop benchmarking studies that track costs and coverages, so you have access to trends and fluctuation and are able to plan accordingly. Examples of our customers include:

• Drug manufacturers and drug wholesale manufacturers
• Biotech firms
• Medical device and supply companies
• Laboratories contract and clinical research and development facilities
• Pharmaceutical companies
• Nutraceutical and food supplement companies
• Medical technology manufacturers
• Clinical trials facilities
• Academic institutions

Thought leadership beyond insurance

Our experience gives us insight into all aspects of the medical and life sciences industry. We share this knowledge by consulting on pricing issues related to managed care organizations, patent expirations, and industry mergers.

Solutions that fuel research breakthroughs

Our practice is designed to help you meet the unique risk challenges of the life sciences' industry, so you can focus on researching medicines and methods. Gallagher Life Sciences insurance and risk management specials are with you through each phase that includes:

Discovery phase — Deep analysis of the complex challenges facing life science companies whether it is for national or global clinical trials to understanding foreign regulatory requirements. During this phase, we look at firm's human resources, availability of funds, Directors & Officers (D&O) insurance, pre-clinical risk advisors and product liability for commercial products.

Development phase — local vs. global coverage programs for cost and coverage effectiveness within the regulatory environment to minimize program costs. Risk analyses and coverages we look at during this phase range from clinical trials, intellectual property, licensing agreements and corporate investments to Errors and Omissions (E&O) insurance to medical malpractice insurance.

Production — Leveraging a comprehensive set of proprietary tools to support implement a strategic risk program for your organization. Key areas of risk management analysis during this phase include supply chain analysis, product safety and recall, business continuity management and enterprise risk management.